{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:44:35Z","timestamp":1792791875400,"version":"4.5.0"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,6]],"date-time":"2024-10-06T00:00:00Z","timestamp":1728172800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81503296"],"award-info":[{"award-number":["81503296"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004731","name":"Zhejiang Province Natural Science Foundation","doi-asserted-by":"publisher","award":["LY21H290003"],"award-info":[{"award-number":["LY21H290003"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2023YFC3503900"],"award-info":[{"award-number":["2023YFC3503900"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002855","name":"Ministry of Science and Technology of the People's Republic of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002855","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Advanced Research"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.jare.2024.10.003","type":"journal-article","created":{"date-parts":[[2024,10,9]],"date-time":"2024-10-09T13:29:52Z","timestamp":1728480592000},"page":"621-635","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Integrated stress response activation induced by usnic acid alleviates BCL-2 inhibitor ABT-199 resistance in acute myeloid leukemia"],"prefix":"10.1016","volume":"74","author":[{"given":"Dijiong","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Man","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaonan","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengtao","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liqin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxiao","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengqian","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiping","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoyin","family":"Kai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.jare.2024.10.003_b0005","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1182\/blood.2022016867","article-title":"Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN","volume":"140","author":"D\u00f6hner","year":"2022","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.jare.2024.10.003_b0010","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1111\/bjh.17746","article-title":"Updates on targeted therapies for acute myeloid leukaemia","volume":"196","author":"Kayser","year":"2022","journal-title":"Br J Haematol"},{"issue":"3","key":"10.1016\/j.jare.2024.10.003_b0015","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1158\/2159-8290.CD-13-0609","article-title":"Selective BCL-2 inhibition by ABT-199 causes on-target cell death in acute myeloid leukemia","volume":"4","author":"Pan","year":"2014","journal-title":"Cancer Discov"},{"issue":"1","key":"10.1016\/j.jare.2024.10.003_b0020","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1182\/blood-2018-08-868752","article-title":"Venetoclax combined with decitabine or azacitidine in treatment-naive, elderly patients with acute myeloid leukemia","volume":"133","author":"DiNardo","year":"2019","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.jare.2024.10.003_b0025","doi-asserted-by":"crossref","first-page":"2795","DOI":"10.1038\/s41375-019-0612-8","article-title":"How we use venetoclax with hypomethylating agents for the treatment of newly diagnosed patients with acute myeloid leukemia","volume":"33","author":"Jonas","year":"2019","journal-title":"Leukemia"},{"issue":"11","key":"10.1016\/j.jare.2024.10.003_b0030","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1182\/blood.2019003988","article-title":"Molecular patterns of response and treatment failure after frontline venetoclax combinations in older patients with AML","volume":"135","author":"DiNardo","year":"2020","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.jare.2024.10.003_b0035","doi-asserted-by":"crossref","first-page":"894","DOI":"10.3324\/haematol.2020.252569","article-title":"Outcomes of relapsed or refractory acute myeloid leukemia after frontline hypomethylating agent and venetoclax regimens","volume":"106","author":"Maiti","year":"2021","journal-title":"Haematologica"},{"issue":"10","key":"10.1016\/j.jare.2024.10.003_b0040","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.15252\/embr.201642195","article-title":"The integrated stress response","volume":"17","author":"Pakos-Zebrucka","year":"2016","journal-title":"EMBO Rep"},{"key":"10.1016\/j.jare.2024.10.003_b0045","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.747837","article-title":"Targeting the integrated stress response in cancer therapy","volume":"12","author":"Tian","year":"2021","journal-title":"Front Pharmacol"},{"issue":"1","key":"10.1016\/j.jare.2024.10.003_b0050","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/s40164-022-00348-0","article-title":"Targeting the integrated stress response in hematologic malignancies","volume":"11","author":"Nwosu","year":"2022","journal-title":"Exp Hematol Oncol"},{"issue":"13","key":"10.1016\/j.jare.2024.10.003_b0055","doi-asserted-by":"crossref","first-page":"3371","DOI":"10.1158\/1078-0432.CCR-19-1900","article-title":"5-Azacitidine induces NOXA to Prime AML cells for venetoclax-mediated apoptosis","volume":"26","author":"Jin","year":"2020","journal-title":"Clin Cancer Res"},{"issue":"516","key":"10.1016\/j.jare.2024.10.003_b0060","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aax2863","article-title":"Inhibition of mitochondrial translation overcomes venetoclax resistance in AML through activation of the integrated stress response","volume":"11","author":"Sharon","year":"2019","journal-title":"Sci Transl Med"},{"issue":"9","key":"10.1016\/j.jare.2024.10.003_b0065","doi-asserted-by":"crossref","first-page":"e1010439","DOI":"10.1371\/journal.pcbi.1010439","article-title":"An integrative systems biology approach to overcome venetoclax resistance in acute myeloid leukemia","volume":"18","author":"Przedborski","year":"2022","journal-title":"PLoS Comput Biol"},{"issue":"26","key":"10.1016\/j.jare.2024.10.003_b0070","doi-asserted-by":"crossref","first-page":"3737","DOI":"10.1182\/blood.2021013277","article-title":"Ceramide-induced integrated stress response overcomes Bcl-2 inhibitor resistance in acute myeloid leukemia","volume":"139","author":"Lewis","year":"2022","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.jare.2024.10.003_b0075","doi-asserted-by":"crossref","first-page":"e22208","DOI":"10.1002\/jbt.22208","article-title":"In vitro cytotoxic and antiproliferative effects of usnic acid on hormone-dependent breast and prostate cancer cells","volume":"32","author":"Eryilmaz","year":"2018","journal-title":"J Biochem Mol Toxicol"},{"issue":"1","key":"10.1016\/j.jare.2024.10.003_b0080","first-page":"115","article-title":"A review of anti-cancer and related properties of lichen-extracts and metabolites","volume":"22","author":"Tripathi","year":"2022","journal-title":"Anticancer Agents Med Chem"},{"key":"10.1016\/j.jare.2024.10.003_b0085","article-title":"Usnea acid as multidrug resistance (MDR) reversing agent against human chronic myelogenous leukemia K562\/ADR cells via an ROS dependent apoptosis","volume":"2019","author":"Wang","year":"2019","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.jare.2024.10.003_b0090","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.freeradbiomed.2022.01.015","article-title":"Dihydrotanshinone I inhibits ovarian tumor growth by activating oxidative stress through Keap1-mediated Nrf2 ubiquitination degradation","volume":"180","author":"Sun","year":"2022","journal-title":"Free Radic Biol Med"},{"issue":"6","key":"10.1016\/j.jare.2024.10.003_b0095","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.cell.2004.05.008","article-title":"Disruption of mitochondrial function during apoptosis is mediated by caspase cleavage of the p75 subunit of complex I of the electron transport chain","volume":"117","author":"Ricci","year":"2004","journal-title":"Cell"},{"issue":"6489","key":"10.1016\/j.jare.2024.10.003_b0100","doi-asserted-by":"crossref","DOI":"10.1126\/science.aat5314","article-title":"The integrated stress response: from mechanism to disease","volume":"368","author":"Costa-Mattioli","year":"2020","journal-title":"Science (New York, NY)"},{"issue":"15","key":"10.1016\/j.jare.2024.10.003_b0105","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1200\/JCO.18.01600","article-title":"Venetoclax combined with low-dose cytarabine for previously untreated patients with acute myeloid leukemia: results from a Phase Ib\/II study","volume":"37","author":"Wei","year":"2019","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.jare.2024.10.003_b0110","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/S1470-2045(18)30010-X","article-title":"Safety and preliminary efficacy of venetoclax with decitabine or azacitidine in elderly patients with previously untreated acute myeloid leukaemia: a non-randomised, open-label, phase 1b study","volume":"19","author":"DiNardo","year":"2018","journal-title":"Lancet Oncol"},{"issue":"415","key":"10.1016\/j.jare.2024.10.003_b0115","doi-asserted-by":"crossref","first-page":"ra17","DOI":"10.1126\/scisignal.aac4380","article-title":"ATF4 induction through an atypical integrated stress response to ONC201 triggers p53-independent apoptosis in hematological malignancies","volume":"9","author":"Ishizawa","year":"2016","journal-title":"Sci Signal"},{"issue":"3","key":"10.1016\/j.jare.2024.10.003_b0120","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1182\/blood-2011-07-366492","article-title":"Activation of ATF4 mediates unwanted Mcl-1 accumulation by proteasome inhibition","volume":"119","author":"Hu","year":"2012","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.jare.2024.10.003_b0125","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1073\/pnas.0807611106","article-title":"ERAD inhibitors integrate ER stress with an epigenetic mechanism to activate BH3-only protein NOXA in cancer cells","volume":"106","author":"Wang","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"issue":"9","key":"10.1016\/j.jare.2024.10.003_b0130","doi-asserted-by":"crossref","first-page":"6091","DOI":"10.1074\/jbc.M109.014092","article-title":"Regulation of endoplasmic reticulum stress-induced cell death by ATF4 in neuroectodermal tumor cells","volume":"285","author":"Armstrong","year":"2010","journal-title":"J Biol Chem"},{"issue":"11","key":"10.1016\/j.jare.2024.10.003_b0135","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.tem.2017.07.003","article-title":"Surviving stress: modulation of ATF4-mediated stress responses in normal and malignant cells","volume":"28","author":"Wortel","year":"2017","journal-title":"Trends Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.jare.2024.10.003_b0140","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1186\/s12885-017-3383-5","article-title":"Potential mechanisms of resistance to venetoclax and strategies to circumvent it","volume":"17","author":"Tahir","year":"2017","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/j.jare.2024.10.003_b0145","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1038\/s41467-019-10363-1","article-title":"Structures of BCL-2 in complex with venetoclax reveal the molecular basis of resistance mutations","volume":"10","author":"Birkinshaw","year":"2019","journal-title":"Nat Commun"},{"issue":"7","key":"10.1016\/j.jare.2024.10.003_b0150","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1158\/2159-8290.CD-19-0125","article-title":"The TP53 apoptotic network is a primary mediator of resistance to BCL2 inhibition in AML cells","volume":"9","author":"Nechiporuk","year":"2019","journal-title":"Cancer Discov"},{"issue":"7","key":"10.1016\/j.jare.2024.10.003_b0155","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1158\/2159-8290.CD-19-0117","article-title":"Targeting mitochondrial structure sensitizes acute myeloid leukemia to venetoclax treatment","volume":"9","author":"Chen","year":"2019","journal-title":"Cancer Discov"},{"issue":"12","key":"10.1016\/j.jare.2024.10.003_b0160","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1038\/s41591-018-0233-1","article-title":"Venetoclax with azacitidine disrupts energy metabolism and targets leukemia stem cells in patients with acute myeloid leukemia","volume":"24","author":"Pollyea","year":"2018","journal-title":"Nat Med"},{"issue":"4","key":"10.1016\/j.jare.2024.10.003_b0165","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1158\/2159-8290.CD-19-0710","article-title":"Monocytic subclones confer resistance to venetoclax-based therapy in patients with acute myeloid leukemia","volume":"10","author":"Pei","year":"2020","journal-title":"Cancer Discov"},{"issue":"6","key":"10.1016\/j.jare.2024.10.003_b0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccell.2020.10.010","article-title":"Reduced mitochondrial apoptotic priming drives resistance to BH3 mimetics in acute myeloid leukemia","volume":"38","author":"Bhatt","year":"2020","journal-title":"Cancer Cell"},{"issue":"6","key":"10.1016\/j.jare.2024.10.003_b0175","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.3324\/haematol.2021.278369","article-title":"AXL\/MERTK inhibitor ONO-7475 potently synergizes with venetoclax and overcomes venetoclax resistance to kill FLT3-ITD acute myeloid leukemia","volume":"107","author":"Post","year":"2022","journal-title":"Haematologica"},{"key":"10.1016\/j.jare.2024.10.003_b0180","doi-asserted-by":"crossref","first-page":"27696","DOI":"10.1038\/srep27696","article-title":"Targeting MCL-1\/BCL-XL forestalls the acquisition of resistance to ABT-199 in acute myeloid leukemia","volume":"6","author":"Lin","year":"2016","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.jare.2024.10.003_b0185","doi-asserted-by":"crossref","first-page":"e1593","DOI":"10.1038\/cddis.2014.525","article-title":"MCL-1 and BCL-xL-dependent resistance to the BCL-2 inhibitor ABT-199 can be overcome by preventing PI3K\/AKT\/mTOR activation in lymphoid malignancies","volume":"6","author":"Choudhary","year":"2015","journal-title":"Cell Death Dis"},{"issue":"7","key":"10.1016\/j.jare.2024.10.003_b0190","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.tcb.2019.03.004","article-title":"Molecular comprehension of Mcl-1: from gene structure to cancer therapy","volume":"29","author":"Senichkin","year":"2019","journal-title":"Trends Cell Biol"},{"issue":"8","key":"10.1016\/j.jare.2024.10.003_b0195","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1007\/s00018-008-8637-6","article-title":"Mcl-1 is a potential therapeutic target in multiple types of cancer","volume":"66","author":"Akgul","year":"2009","journal-title":"Cell Mol Life Sci"},{"issue":"2","key":"10.1016\/j.jare.2024.10.003_b0200","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1593\/tlo.08223","article-title":"Endogenous Noxa determines the strong proapoptotic synergism of the BH3-mimetic ABT-737 with chemotherapeutic agents in human melanoma cells","volume":"2","author":"Weber","year":"2009","journal-title":"Transl Oncol"},{"issue":"12","key":"10.1016\/j.jare.2024.10.003_b0205","doi-asserted-by":"crossref","first-page":"3069","DOI":"10.1158\/0008-5472.CAN-11-4106","article-title":"Mcl-1 Phosphorylation defines ABT-737 resistance that can be overcome by increased NOXA expression in leukemic B cells","volume":"72","author":"Mazumder","year":"2012","journal-title":"Cancer Res"},{"issue":"2","key":"10.1016\/j.jare.2024.10.003_b0210","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/s41418-019-0486-3","article-title":"Saga of Mcl-1: regulation from transcription to degradation","volume":"27","author":"Senichkin","year":"2020","journal-title":"Cell Death Differ"},{"issue":"31","key":"10.1016\/j.jare.2024.10.003_b0215","doi-asserted-by":"crossref","first-page":"5301","DOI":"10.1038\/sj.onc.1207692","article-title":"MCL1 is phosphorylated in the PEST region and stabilized upon ERK activation in viable cells, and at additional sites with cytotoxic okadaic acid or taxol","volume":"23","author":"Domina","year":"2004","journal-title":"Oncogene"},{"issue":"6","key":"10.1016\/j.jare.2024.10.003_b0220","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.molcel.2006.02.009","article-title":"Glycogen synthase kinase-3 regulates mitochondrial outer membrane permeabilization and apoptosis by destabilization of MCL-1","volume":"21","author":"Maurer","year":"2006","journal-title":"Mol Cell"}],"container-title":["Journal of Advanced Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2090123224004363?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2090123224004363?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T10:50:58Z","timestamp":1762599058000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2090123224004363"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":44,"alternative-id":["S2090123224004363"],"URL":"https:\/\/doi.org\/10.1016\/j.jare.2024.10.003","relation":{},"ISSN":["2090-1232"],"issn-type":[{"value":"2090-1232","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Integrated stress response activation induced by usnic acid alleviates BCL-2 inhibitor ABT-199 resistance in acute myeloid leukemia","name":"articletitle","label":"Article Title"},{"value":"Journal of Advanced Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jare.2024.10.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V. on behalf of Cairo University","name":"copyright","label":"Copyright"}]}}